RESPONSE BIOMEDICAL CORP Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2018-04-25: Study NCT03485313; Company role Lead sponsor; Phase Observational; Status Terminated.
- 2015-10: Study NCT02591121; Company role Lead sponsor; Phase Observational; Status Completed.
- 2014-07: Study NCT02191735; Company role Lead sponsor; Phase Observational; Status Completed.
- 2008-02: Study NCT00636662; Company role Lead sponsor; Phase Observational; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2018-04-25 | NCT03485313 Beta-hCG Test Reference Range Determination | Lead sponsor | Observational | Terminated | Healthy | 137 | 2018-08-29 |
| 2015-10 | NCT02591121 Procalcitonin Test Reference Range Determination | Lead sponsor | Observational | Completed | Healthy | 125 | 2015-10 |
| 2014-07 | NCT02191735 RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care | Lead sponsor | Observational | Completed | Acute Coronary Syndrome; Myocardial Infarction; Heart Failure; Congestive Heart Failure | 719 | 2014-12 |
| 2008-02 | NCT00636662 FLU A+B Nasal Swab Clinical Study | Lead sponsor | Observational | Completed | Influenza | 800 | 2008-05 |